
Vietnam’s pharmaceutical industry is experiencing unprecedented growth. Driven by a rapidly aging population, increasing government healthcare expenditure, and a strong national push to reduce reliance on imported medicines, the domestic generic drug market is booming.
As we move through 2026, the landscape of pharma manufacturing in Vietnam is shifting. The most significant trend? A massive transition from basic WHO-GMP compliance to the rigorous EU-GMP and PIC/S standards. This shift allows Vietnamese manufacturers to not only dominate the local hospital bidding channels but also export their generic drugs to global markets.
Whether you are a B2B distributor, an investor, or a pharmaceutical equipment supplier, understanding the key players is crucial. Based on production capacity, market share, and technological advancement, here are the Top 10 Generic Pharma Manufacturing Companies in Vietnam for 2026.
Table of Contents
ToggleAs the undisputed leader in Vietnam’s pharmaceutical sector, DHG Pharma boasts the largest market share in domestic generic drugs. Backed by Japan’s Taisho Pharmaceutical, DHG has successfully upgraded several of its production lines to Japan-GMP standards, focusing heavily on analgesics, antibiotics, and cardiovascular generics.
Imexpharm is the pioneer of high-quality antibiotics in Vietnam. They were among the first domestic companies to invest heavily in EU-GMP standard factories. Their unwavering commitment to European manufacturing standards has made them the top choice for premium generic medicines in Vietnam’s tier-1 hospitals.
While traditionally famous for herbal and traditional medicines, Traphaco has aggressively expanded into the modern generic drug space. With their new, highly automated smart factories, they have scaled up the production of OTC and prescription generics, setting a benchmark for modern pharma manufacturing in Northern Vietnam.
Fully acquired by the global generic giant STADA, Pymepharco is a manufacturing powerhouse. Operating multiple state-of-the-art EU-GMP certified plants in Phu Yen, they produce a vast portfolio of high-quality generics that supply both the domestic market and STADA’s global supply chain.
With major backing from Abbott, Domesco has solidified its position in the generic prescription drug market. They specialize in treatments for chronic diseases, particularly cardiovascular and endocrine system disorders, utilizing advanced formulation and tableting technologies.
With a rich history dating back to 1950, OPV Pharmaceutical is a prominent manufacturer of both prescription and OTC healthcare products. Recently acquired by RV Group, OPV is aggressively upgrading its manufacturing capabilities to improve access to affordable, high-quality medicines across Indochina.
Bidiphar stands out for its specialized manufacturing capabilities. They are the leading domestic producer of generic oncology drugs (cancer treatments) and sterile injectables. Handling such highly potent active pharmaceutical ingredients (APIs) requires world-class isolation and mixing equipment.
Partnered with Japan’s ASKA Pharmaceutical, Hataphar is rapidly expanding its production capacity. They are currently building new high-tech manufacturing facilities designed to meet Japan-GMP and EU-GMP standards, focusing on high-volume generic solid dosages.
While primarily known for its pioneering work in biologics and vaccines, Nanogen is a crucial player in the broader therapeutic solutions market. Their highly advanced R&D and manufacturing capabilities for APIs and biosimilars represent the cutting edge of Vietnam’s life science sector.
A rising star in the Vietnamese market, Innocare focuses heavily on innovative R&D and specialized generic formulations. They have carved out a strong niche in dermatological treatments and advanced spray formulations, proving that Vietnamese manufacturers are moving beyond basic pills and capsules.
What do industry giants like Imexpharm, DHG, and Pymepharco have in common? They do not compromise on their manufacturing equipment.
To pass strict EU-GMP audits and secure lucrative government hospital contracts, Vietnamese pharmaceutical companies are rapidly replacing outdated machinery with premium, highly automated equipment. Consistent drug efficacy relies entirely on the precision of the manufacturing process.
At Jianpai Technology, we supply the world-class pharmaceutical machinery that powers top-tier generic manufacturing globally:
Vietnam’s leading generic producers are upgrading plants to EU-GMP and PIC/S standards to win higher-tier hospital tenders and export contracts. This drives demand for equipment that is easy to clean, records batch data and keeps the process closed, while staying cost-effective for a price-competitive market.
| Production need | Why it matters in Vietnam | Recommended equipment |
|---|---|---|
| Scalable wet granulation | Generic portfolios run many products at different batch sizes | JHZ-C / JHZ-D high shear mixer granulators |
| Efficient drying | Hot, humid climates make moisture control of granules critical | JFG-C fluid bed dryer with closed feeding and discharge |
| Granule sizing and blending | Uniform particle size supports content uniformity | JZL sizing granulator and JPH three-eccentricity mixer |
| Film and enteric coating | Moisture protection, taste masking and modified release for generics | JGB-D / JGB-E tablet coating machines |
| Closed, linked processing | Supports EU-GMP and PIC/S expectations on containment and cross-contamination | totally enclosed granulating production line |
Manufacturers upgrading an existing plant usually start with the bottleneck step, often granulation or coating, and then link equipment into a closed line. See how to plan an efficient solid dosage production line and our buyer’s guide to sourcing pharma machinery from China.
Major names include DHG Pharma, Imexpharm, Traphaco, Pymepharco, Domesco, OPV, Bidiphar, Hataphar, Nanogen and Innocare, as profiled above.
Leading Vietnamese manufacturers increasingly invest in EU-GMP or PIC/S-level facilities, which help them win higher tiers in public hospital tenders and access export markets.
A typical tablet line includes a high shear granulator, fluid bed dryer, sizing mill, blender, tablet press and coating machine, ideally linked with closed material transfer.
Equipment is one part of compliance. Buyers should check stainless steel contact parts, cleanability, documentation (DQ/IQ/OQ support) and data recording, and validate the equipment in their own facility.
JIANPAI supplies granulation, drying, milling, blending and coating equipment for oral solid dosage plants in Southeast Asia. Tell us your products and capacity for a proposal.
Email: [email protected] | Tel: +86 577-86932456 | No. 989 Lingde Road, Oujiangkou New District, Wenzhou, Zhejiang, China